Abstract:Genome information directed OSMAC from deep‐sea derived Penicillium sp. SCSIO sof101. Marine fungi are considered important resources for new lead compounds in One Strain Many Compounds (OSMAC) strategy. In particular, deep‐sea derived fungi have been deemed potent for novel bioactive structures due to their extreme living environment and evolution of special biosynthetic gene clusters (BGCs) for secondary metabolites. Chemical investigations of the deep‐sea derived Penicillium sp. SCSIO sof101 led to the discovery of 5 types of 21 bioactive compounds, including the significant anti‐Gram‐negative bacterial compound sulfoxanthicillin. Bioinformatics analysis of the strain revealed 56 BGCs for the secondary metabolites. This information guided the further culture optimization, which led to the discovery of another five types of secondary metabolites (1–11), including one non‐ribosomal peptide and polyketide (NRP–PK) type compounds (1–3), which included a new compound (1), one NRP type compounds (4–5), and three PK types compounds (6–11). The structure of compound 1 was elucidated by spectral analyses including HR‐ESI‐MS, 1D and 2D NMR, and chemical derivatization approaches. Compound 1 was inactive in the evaluation of antibacterial activity and cytotoxicity. Its biosynthetic pathway was proposed. This finding paves the way for further mining of OSMAC potent from the deep‐sea derived strain.

Investigation on Metabolites in Structure and Biosynthesis from the Deep-Sea Sediment-Derived Actinomycete Janibacter sp. SCSIO 52865

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Isolation and Structure Elucidation of New Metabolites from the Mariana-Trench-Associated Fungus Aspergillus Sp. SY2601.

Secondary Metabolites and Biosynthetic Gene Clusters Analysis of Deep-Sea Hydrothermal Vent-Derived Streptomyces sp. SCSIO ZS0520

Cytotoxic Metabolites from the Marine-Associated Streptomyces Sp. ZZ1944

Induction of New Aromatic Polyketides from the Marine Actinobacterium Streptomyces griseorubiginosus through an OSMAC Approach

Cyclodipeptides from the Secondary Metabolites of Two Novel Actinomycetes

NMR-Metabolomic Profiling and Genome Mining Drive the Discovery of Cyclic Decapeptides from a Marine Streptomyces.

New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete Streptomyces Sp. SY1965

OSMAC Investigation Directed by Genome Information Led to the Discovery of Additional Five Types of Secondary Metabolites From Deep‐Sea Derived Penicillium Sp. SCSIO sof101

Secondary Metabolites from Marine Actinomycete Streptomyces Sp.(no.30701)

[Isolation, Identification and Structural Characterization of Secondary Metabolites from Amarine Sponge-Derived Rare Actinobacterium Dermacoccus Sp. X4].

Structurally Diverse Metabolites from the Marine‐Derived Streptomyces sp. DS‐27 Based on Two Different Culture Conditions

Discovery, Structure Correction, and Biosynthesis of Actinopyrones, Cytotoxic Polyketides from the Deep-Sea Hydrothermal-Vent-Derived <i>Streptomyces</i> sp. SCSIO ZS0520

New Secondary Metabolites Produced by an Engineered Strain Streptomyces Sp. XZQH13OEΔastC.

A New Cyclododeca[D]Oxazole Derivative from Streptomyces Spp. Cibyl1

A new diketopiperazine derivative from a deep sea-derived Streptomyces sp. SCSIO 04496

Structures and Biosynthesis of the Pyridinopyrones, Polyenepyrones from a Marine-Derived Streptomyces Species.

Investigation on taxonomy, secondary metabolites and antibacterial activity of Streptomyces sediminicola sp. nov., a novel marine sediment-derived Actinobacteria

Genomic Analysis of Kitasatospora setae to Explore Its Biosynthetic Potential Regarding Secondary Metabolites